I. Mrdovic

发表

Impact of platelet phenotype on myocardial infarction

I. Mrdović, P. Kruzliak, R. Ciccocioppo, 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

The correlation between metabolic syndrome quantification scores and numerous laboratory parameters related to this syndrome

V. Dimitrijevic-Sreckovic, I. Mrdović, M. Resan, 2020 .

Modern clinical retrospective on ventricular rhythm disturbances in acute myocardial infarction: Latest treatment mode according to the valid recommendations

I. Mrdović, L. Savic, J. Perunicić, 2015 .

TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) SYSTEM

T. Potpara, A. Ristic, D. Lovic, 2015 .

Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial

I. Mrdović, L. Savic, M. Ašanin, 2012, Coronary artery disease.

Impact of kidney function on the occurrence of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction.

L. Savic, M. Ašanin, R. Lasica, 2021, Anatolian journal of cardiology.

Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation

D. Popović, I. Mrdović, L. Savic, 2022, Medicina.

B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

I. Mrdović, L. Savic, M. Ašanin, 2012, Peptides.

The Long‐Term Risk of Stroke in Patients with Acute Myocardial Infarction Complicated with New‐Onset Atrial Fibrillation

I. Mrdović, M. Ašanin, J. Perunicić, 2009, Clinical cardiology.

Significance of recurrences of new atrial fibrillation in acute myocardial infarction.

I. Mrdović, M. Ašanin, J. Marinković, 2006, International journal of cardiology.

Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction

I. Mrdović, M. Ašanin, J. Perunicić, 2005, European journal of heart failure.

Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary intervention.

L. Savic, M. Ašanin, J. Marinković, 2012, Journal of interventional cardiology.

Usefulness of NT-proBNP in the Follow-Up of Patients after Myocardial Infarction

J. Marinković, P. Kruzliak, B. Beleslin, 2016, Journal of medical biochemistry.

Homocysteine is a marker for metabolic syndrome and atherosclerosis.

I. Soldatovic, M. Šumarac-Dumanović, E. Čolak, 2017, Diabetes & metabolic syndrome.

Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.

I. Mrdović, L. Savic, M. Ašanin, 2007, American heart journal.

Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study.

Zorana Vasiljevic, I. Mrdović, L. Savic, 2009, Journal of interventional cardiology.

Gender differences in the prognostic impact of chronic kidney disease in patients with left ventricular systolic dysfunction following ST elevation myocardial infarction treated with primary percutaneous coronary intervention.

I. Mrdović, L. Savic, M. Ašanin, 2016, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

I. Mrdović, L. Savic, M. Ašanin, 2013, The Canadian journal of cardiology.

Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score.

Zorana Vasiljevic, Nikola Kocev, I. Mrdović, 2013, International journal of cardiology.

Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register

I. Mrdović, L. Savic, M. Ašanin, 2014, European heart journal. Acute cardiovascular care.

Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention

M. Marjanović, L. Savic, M. Ašanin, 2013, Heart.

Is the level of evidence for the use of beta-blockers in acute myocardial infarction satisfactory enough?

I. Mrdović, I. Mrdovic, 2005, European heart journal.

Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome

M. Zdravković, N. Milic, B. Filipovic, 2017, Croatian medical journal.

Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary intervention.

L. Savic, M. Ašanin, R. Lasica, 2023, Scandinavian cardiovascular journal : SCJ.

Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era

D. Popović, A. Ristic, I. Mrdović, 2022, Journal of clinical medicine.

Transient Left Ventricular Apical Ballooning Complicated by a Mural Thrombus and Outflow Tract Obstruction

M. Ašanin, J. Perunicić, Z. Vasiljević, 2008 .

Transient left ventricular apical ballooning complicated by a mural thrombus and outflow tract obstruction in a patient with pheochromocytoma.

I. Mrdović, M. Ašanin, J. Perunicić, 2008, Texas Heart Institute journal.

[Prognostic significance of acute bundle branch block in patients with acute myocardial infarction].

I. Mrdović, M. Ašanin, D. Rajić, 2008, Vojnosanitetski pregled.

Early and Late Mortality Predictors in Patients with Acute Aortic Dissection Type B

M. Ašanin, J. Perunicić, R. Lasica, 2022, Cardiology research and practice.

Temporal variations at the onset of spontaneous acute aortic dissection.

I. Mrdović, J. Perunicić, N. Milic, 2006, International heart journal.

Percutaneous implantation of self-expandable aortic valve in high risk patients with severe aortic stenosis: The first experiences in Serbia.

I. Mrdović, B. Beleslin, M. Tesic, 2016, Vojnosanitetski pregled.

Time-dependent changes of myeloperoxidase in relation to in-hospital mortality in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

L. Savic, M. Ašanin, J. Marinković, 2012, Clinical biochemistry.

Modern treatment of acute myocardial infarction with ST-segment elevation complicated with out-of-hospital cardiac arrest

I. Mrdović, M. Ašanin, M. Nedeljkovic, 2018 .

Prognostic significance of dipping in older hypertensive patients

L. Malan, K. Takazawa, P. Kruzliak, 2015, Blood pressure.

Simple risk algorithm to predict serious bleeding in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: RISK-PCI bleeding score.

I. Mrdović, L. Savic, M. Ašanin, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Myocardial Reinfarction in a Patient with Coronary Ectasia

I. Mrdović, M. Ašanin, J. Perunicić, 2004, Cardiology.

Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary Intervention

I. Mrdović, L. Savic, M. Ašanin, 2016, Cardiovascular Drugs and Therapy.

Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention

I. Mrdović, L. Savic, M. Ašanin, 2019, Journal of interventional cardiology.

Author`s Reply

L. Savic, M. Ašanin, R. Lasica, 2018, Anatolian journal of cardiology.

[Hospital mortality trend analysis of patients with ST elevation myocardial infarction in the Belgrade area coronary care units].

N. Kocev, S. Dimković, B. Stefanović, 2008, Srpski arhiv za celokupno lekarstvo.

Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.

I. Mrdović, L. Savic, M. Ašanin, 2013, Journal of interventional cardiology.

Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention.

M. Marjanović, I. Mrdović, M. Ašanin, 2015, Vojnosanitetski pregled.

Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention Učestalost, prediktori i prognozni značaj krvarenja kao komplikacije primarne perkutane koronarne intervencije

M. Marjanović, I. Mrdović, M. Ašanin, 2015 .

The Impact of Kidney Function on the Slow-Flow/No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention: Registry Analysis

L. Savic, M. Ašanin, R. Lasica, 2022, Journal of interventional cardiology.

Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial

I. Mrdović, L. Savic, M. Ašanin, 2013, Heart and Vessels.

Glucose-insulin-potassium therapy in acute myocardial infarction: Ten years follow-up

L. Savic, M. Ašanin, G. Stanković, 2015 .

Impact of the combined presence of left ventricular systolic and renal dysfunction on the 5-year outcome after ST-elevation myocardial infarction.

I. Mrdović, L. Savic, M. Ašanin, 2015, Vojnosanitetski pregled.

Low On-Treatment Platelet Reactivity Predicts Long-Term Risk of Bleeding After Elective PCI.

I. Mrdović, J. Marinković, P. Kruzliak, 2015, Journal of interventional cardiology.

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome

I. Mrdović, J. Perunicić, M. Djokic, 2008, Journal of Thrombosis and Thrombolysis.

Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial Infarction

L. Savic, M. Ašanin, R. Lasica, 2023, Journal of personalized medicine.

Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.

I. Mrdović, L. Savic, M. Ašanin, 2013, International journal of cardiology.

Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions.

V. Kanjuh, M. Ćulafić, M. Kocica, 2017, Current drug metabolism.

Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score

V. Dimitrijevic-Sreckovic, I. Mrdović, I. Soldatovic, 2018, Drug metabolism and personalized therapy.

Oxidative stress markers predict early left ventricular systolic dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.

I. Mrdović, M. Ašanin, O. Djuric, 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

'Triple therapy' in high risk patient after primary PCI: Case report and practical application of current ESC and ACC/AHA guidelines

I. Mrdović, M. Ašanin, S. Stojkovic, 2016 .

High-dose streptokinase in the treatment of acute massive pulmonary embolism complicated with cardiogenic shock, respiratory arrest and ventricular fibrillation.

I. Mrdović, J. Perunicić, R. Lasica, 2005, Vojnosanitetski pregled.

Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention

M. Marjanović, M. Ašanin, J. Marinković, 2019, Heart.

Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention.

I. Mrdović, L. Savic, M. Ašanin, 2010, The Journal of invasive cardiology.

Impact of access and nonaccess site bleeding measured by Bleeding Academic Research Consortium (BARC) criteria on long-term outcome in patients treated with primary percutaneous coronary intervention

M. Marjanović, M. Ašanin, G. Stanković, 2013 .